Apr 2 |
Eli Lilly’s Ozempic Competitors Face Risks. Why the Stock Has More Upside.
|
Apr 2 |
Meta Platforms, AMD Lead 10 Stocks Showing This Bullish Action
|
Apr 2 |
Verve drops after pausing trial enrollments for lead asset
|
Apr 2 |
Outperforming ETF manager names a potential ‘50-bagger’ in the stock market
|
Apr 2 |
The Zacks Analyst Blog Highlights Apple, NVIDIA, Eli Lilly, American Tower and McKesson
|
Apr 2 |
Is It Too Late to Buy Eli Lilly Stock?
|
Apr 1 |
Top Stock Reports for Apple, NVIDIA & Eli Lilly
|
Apr 1 |
Missed the "Magnificent Seven"? Try Buying These 3 Forever Stocks Instead
|
Apr 1 |
Meet The "Magnificent Seven" of Healthcare Stocks
|
Apr 1 |
20 Most Obese Countries in Asia
|